Channel Avatar

Nordic Bioscience @[email protected]

2.2K subscribers - no pronouns :c

Nordic Bioscience is the leading expert in extracellular mat


57:28
Webinar | 30+ Years of Lessons Learned in Clinical Trials and Unicorn Biomarkers
01:28:30
Webinar | Translational Science in Pulmonary Fibrosis: From patients to cells and back
01:28:00
Webinar | Metabolic Activation of Fibroblasts in Obesity and Related Disorders
01:39:36
Webinar | Fibrosis as a Driver of Cancer, Liver, and Heart-related Outcomes
01:35:53
Webinar | Precision Medicine in Lung Diseases: New Developments
02:11
Eosinophilic Esophagitis (EoE) | Differentiating Patients with Blood-based Collagen Biomarkers
01:32:16
Webinar | Arthritic Diseases: Fibroblasts and Tissue Destruction
01:30:50
Webinar | Tumor Fibrosis in Cancer: Fibroblast Activities and New Biomarkers
01:28:35
Webinar | HFpEF and Extracellular Matrix Dysregulation: Novel Treatment Strategies
01:32:56
Webinar | Serum Calprotectin and Mucosal Damage in IBD
02:58
Neutrophils and Neutrophil Extracellular Traps (NETs) in IBD | Serum Calprotectin CPa9-HNE Biomarker
01:35
NEJM Evidence Publication in Heart Failure by Nordic Bioscience and Collaborators
01:43
Fibrosis, The Failing Heart, and Endotrophin | Nordic Bioscience
01:36
Patient Segregation in Heart Failure with Preserved Ejection Fraction
01:52
Protein Quantification: The right epitope of the right protein
01:24
Rheumatoid Arthritis | Joint Inflammation Animation | Joint Tissue Profiling
02:22
Heart Failure (HFpEF) | Endotrophin as a Novel Biomarker | PRO-C6
02:54
Cancer Research | Tumor Fibrosis Biomarkers | Immune Checkpoint Inhibitor Therapy
02:49
Pulmonary Fibrosis | Translational Biomarkers | PRO-C6
04:47
Extracellular Matrix Animation: Quantifying Tissue Remodeling through the Nordic ProteinFingerPrintā„¢
02:17
Alzheimer's | Early Detection of Neuron Loss | Tau-C Biomarker
32:31
Rheumatoid Arthritis and Psoriatic Arthritis | Blood-Based Tissue Profiling
34:42
Cardiovascular Diseases | From Atherosclerosis to Heart Failure (HFpEF)
28:04
Respiratory Diseases | Idiopathic Pulmonary Fibrosis and COPD | Beyond The Interstitial Matrix
24:21
In Vitro Diagnostic product (IVD) Approval in 2022 - CLSI Standards Regulatory Landscape
34:24
Liver Fibrosis | NASH and NAFLD | The balance between formation and degradation in the ECM
28:21
Kidney Fibrosis | Turnover of The Interstitial ECM as a Predictor of Adverse Outcomes
35:14
Cancer Research | The Extracellular Matrix in Oncology
31:31
Inflammatory Bowel Disease | Crohn's Disease and IBD Early Treatment Response
37:07
The Extracellular Matrix (ECM) | The Common Denominator In All Chronic Diseases